Raynaud phenomenon

Last updated: November 01, 2022

Raynaud phenomenon

Revision

Revision

Anemia: Clinical
Microcytic anemia: Pathology review
Non-hemolytic normocytic anemia: Pathology review
Intrinsic hemolytic normocytic anemia: Pathology review
Extrinsic hemolytic normocytic anemia: Pathology review
Macrocytic anemia: Pathology review
Leukemia: Clinical
Lymphoma: Clinical
Thrombocytopenia: Clinical
Bleeding disorders: Clinical
Thrombophilia: Clinical
Myeloproliferative neoplasms: Clinical
Plasma cell disorders: Clinical
Blood products and transfusion: Clinical
Anticoagulants: Heparin
Anticoagulants: Warfarin
Anticoagulants: Direct factor inhibitors
Antiplatelet medications
Thrombolytics
Hematopoietic medications
Ribonucleotide reductase inhibitors
Topoisomerase inhibitors
Platinum containing medications
Anti-tumor antibiotics
Microtubule inhibitors
DNA alkylating medications
Endocrine system anatomy and physiology
Risk factors for periodontitis
Anatomy of the thyroid and parathyroid glands
Diabetes mellitus: Clinical
Hyperthyroidism: Clinical
Hypothyroidism and thyroiditis: Clinical
Parathyroid conditions and calcium imbalance: Clinical
Thyroid nodules and thyroid cancer: Clinical
Pituitary adenomas and pituitary hyperfunction: Clinical
Hypopituitarism: Clinical
Cushing syndrome: Clinical
Adrenal masses and tumors: Clinical
MEN syndromes: Clinical
Hyperthyroidism medications
Hypothyroidism medications
Insulins
Hypoglycemics: Insulin secretagogues
Miscellaneous hypoglycemics
Adrenal hormone synthesis inhibitors
Mineralocorticoids and mineralocorticoid antagonists
Glucocorticoids
HIV (AIDS)
Human herpesvirus 8 (Kaposi sarcoma)
Chronic kidney disease: Clinical
Chronic obstructive pulmonary disease (COPD): Clinical
Obstructive lung diseases: Pathology review
Inflammatory bowel disease: Clinical
Supraventricular arrhythmias: Pathology review
Ventricular arrhythmias: Pathology review
Heart blocks: Pathology review
Coronary artery disease: Clinical
Heart failure: Clinical
Syncope: Clinical
Pericardial disease: Clinical
Infective endocarditis: Clinical
Valvular heart disease: Clinical
Cardiomyopathies: Clinical
Hypertension: Clinical
Hypercholesterolemia: Clinical
Sympatholytics: Alpha-2 agonists
Adrenergic antagonists: Presynaptic
Adrenergic antagonists: Alpha blockers
Adrenergic antagonists: Beta blockers
ACE inhibitors, ARBs and direct renin inhibitors
Thiazide and thiazide-like diuretics
Calcium channel blockers
cGMP mediated smooth muscle vasodilators
Class I antiarrhythmics: Sodium channel blockers
Class II antiarrhythmics: Beta blockers
Class III antiarrhythmics: Potassium channel blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Lipid-lowering medications: Statins
Lipid-lowering medications: Fibrates
Miscellaneous lipid-lowering medications
Positive inotropic medications
Loop diuretics
Osteogenesis imperfecta
Acyanotic congenital heart defects: Pathology review
Cyanotic congenital heart defects: Pathology review
Cardiomyopathies: Pathology review
Heart failure: Pathology review
Systemic lupus erythematosus (SLE): Clinical
Diabetic retinopathy
Diabetic nephropathy
Congenital adrenal hyperplasia
Primary adrenal insufficiency
Waterhouse-Friderichsen syndrome
Hyperaldosteronism
Adrenal cortical carcinoma
Cushing syndrome
Conn syndrome
Thyroglossal duct cyst
Hyperthyroidism
Graves disease
Thyroid eye disease (NORD)
Toxic multinodular goiter
Thyroid storm
Hypothyroidism
Euthyroid sick syndrome
Hashimoto thyroiditis
Subacute granulomatous thyroiditis
Riedel thyroiditis
Thyroid cancer
Hyperparathyroidism
Hypoparathyroidism
Hypercalcemia
Hypocalcemia
Diabetes mellitus
Hyperpituitarism
Pituitary adenoma
Hyperprolactinemia
Prolactinoma
Gigantism
Acromegaly
Hypopituitarism
Pituitary apoplexy
Sheehan syndrome
Hypoprolactinemia
Constitutional growth delay
Diabetes insipidus
Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Precocious puberty
Delayed puberty
Premature ovarian failure
Polycystic ovary syndrome
Androgen insensitivity syndrome
Kallmann syndrome
5-alpha-reductase deficiency
Autoimmune polyglandular syndrome type 1 (NORD)
Multiple endocrine neoplasia
Pancreatic neuroendocrine neoplasms
Zollinger-Ellison syndrome
Pheochromocytoma
Neuroblastoma
Opsoclonus myoclonus syndrome (NORD)
Adrenal insufficiency: Pathology review
Adrenal masses: Pathology review
Hyperthyroidism: Pathology review
Hypothyroidism: Pathology review
Thyroid nodules and thyroid cancer: Pathology review
Parathyroid disorders and calcium imbalance: Pathology review
Diabetes mellitus: Pathology review
Cushing syndrome and Cushing disease: Pathology review
Pituitary tumors: Pathology review
Hypopituitarism: Pathology review
Diabetes insipidus and SIADH: Pathology review
Multiple endocrine neoplasia: Pathology review
Immune thrombocytopenia
Mixed platelet and coagulation disorders: Pathology review
Hypertension
Heparin-induced thrombocytopenia
Raynaud phenomenon
Nephritic syndromes: Pathology review
Down syndrome (Trisomy 21)
Rett syndrome
Restrictive lung diseases: Pathology review
Sarcoidosis
Parkinson disease
Cranial nerves
Spina bifida
Chiari malformation
Dandy-Walker malformation
Syringomyelia
Tethered spinal cord syndrome
Aqueductal stenosis
Septo-optic dysplasia
Cerebral palsy
Spinocerebellar ataxia (NORD)
Transient ischemic attack
Ischemic stroke
Intracerebral hemorrhage
Epidural hematoma
Subdural hematoma
Subarachnoid hemorrhage
Saccular aneurysm
Arteriovenous malformation
Broca aphasia
Wernicke aphasia
Wernicke-Korsakoff syndrome
Kluver-Bucy syndrome
Concussion and traumatic brain injury
Shaken baby syndrome
Seizures and epilepsy
Febrile seizure
Early infantile epileptic encephalopathy (NORD)
Tension headache
Cluster headache
Migraine
Idiopathic intracranial hypertension
Trigeminal neuralgia
Cavernous sinus thrombosis
Alzheimer disease
Vascular dementia
Frontotemporal dementia
Dementia with Lewy bodies
Creutzfeldt-Jakob disease
Normal pressure hydrocephalus
Torticollis
Essential tremor
Restless legs syndrome
Parkinson disease
Huntington disease
Multiple sclerosis
Central pontine myelinolysis
Acute disseminated encephalomyelitis
Transverse myelitis
JC virus (Progressive multifocal leukoencephalopathy)
Adult brain tumors
Acoustic neuroma (schwannoma)
Pediatric brain tumors
Brain herniation
Brown-Sequard Syndrome
Cauda equina syndrome
Treponema pallidum (Syphilis)
Vitamin B12 deficiency
Friedreich ataxia
Neurogenic bladder
Meningitis
Neonatal meningitis
Encephalitis
Brain abscess
Epidural abscess
Sturge-Weber syndrome
Tuberous sclerosis
Neurofibromatosis
von Hippel-Lindau disease
Amyotrophic lateral sclerosis
Spinal muscular atrophy
Poliovirus
Guillain-Barre syndrome
Charcot-Marie-Tooth disease
Bell palsy
Winged scapula
Thoracic outlet syndrome
Carpal tunnel syndrome
Ulnar claw
Erb-Duchenne palsy
Klumpke paralysis
Sciatica
Myasthenia gravis
Lambert-Eaton myasthenic syndrome
Orthostatic hypotension
Horner syndrome
Congenital neurological disorders: Pathology review
Headaches: Pathology review
Seizures: Pathology review
Cerebral vascular disease: Pathology review
Traumatic brain injury: Pathology review
Spinal cord disorders: Pathology review
Dementia: Pathology review
Central nervous system infections: Pathology review
Movement disorders: Pathology review
Neuromuscular junction disorders: Pathology review
Demyelinating disorders: Pathology review
Adult brain tumors: Pathology review
Pediatric brain tumors: Pathology review
Neurocutaneous disorders: Pathology review

Transcript

Watch video only

Raynaud phenomenon is a phenomenon where there’s vasoconstriction of arteries near the skin that make a body part, often the fingers, turn white, then blue, and then red in response to a trigger like cold weather.

The phenomenon is named after Auguste Gabriel Maurice Raynaud, a French physician, who first described it.

To clear up some potentially confusing terminology, it’s called Raynaud disease or primary Raynaud phenomenon where the condition occurs alone and is not associated with any other disease, and it’s called Raynaud syndrome or secondary Raynaud phenomenon when it is associated with diseases like systemic lupus erythematosus or scleroderma.

Normally blood flows from large arteries into medium-sized or muscular arteries, and then into small arterioles which carry the blood to capillary beds.

All arterial vessels have three layers: from inside moving out, there’s the endothelium, then the media layer which contains smooth muscle, and finally the adventitia layer which has loose connective tissue and nerves.

Some nerve fibers in the skin function as thermoreceptors, which sense changes in temperature.

When stimulated, they cause the nerve to fire, sending signals up through the spinal cord to the hypothalamus, which is at the base of the brain.

The hypothalamus serves as the body’s thermostat because it coordinates the brain’s response to temperature changes.

The hypothalamus is what triggers the thought – “Hey, it’s pretty cold here. Maybe I should find a friendly llama to snuggle with for warmth.”

The hypothalamus also coordinates changes in the sympathetic and parasympathetic nervous system.

For example, normally, there’s a lot of heat energy in the blood, that gets lost to the environment.

When the sympathetic nervous system gets stimulated it causes contraction of smooth muscle that wraps around arterioles causing vasoconstriction and a reduction of blood flow to the skin.

That shunts blood away from the skin and towards the body’s core or organs where less heat energy is lost.

In Raynaud phenomenon, triggers like the cold or even emotional stress cause sympathetic nerves in the walls of arterioles to get overstimulated, and that makes the arterioles vasoconstrict.

If the vasoconstriction happens briefly or intermittently it’s called vasospasm.

When the arterioles vasoconstrict it dramatically decreases blood flow to downstream tissue.

For example, if there’s vasospasm in the arterioles in the fingers, it causes the fingers to turn white reflecting ischemia, then blue reflecting hypoxia, which is the low oxygen state that occurs after prolonged ischemia.

Finally, once the vasospasm ends, oxygenated blood rushes into the tissue, causing what’s called reactive hyperemia, which makes the fingers look red.

Key Takeaways

Raynaud phenomenon is a condition in which due to cold temperatures or emotional stress, blood vessels in the fingers and toes constrict and restrict blood supply in affected areas. This can cause symptoms like numbness, tingling, brittle nails, and pain in the affected areas. In severe cases, fingers may turn white, reflecting ischemia, and then blue reflecting hypoxia, which is the low oxygen state that occurs after prolonged ischemia.

Raynaud phenomenon is common among pregnant women and people who work in jobs that cause lots of vibration, like using a jackhammer. It may also be a symptom of underlying conditions, such as systemic lupus erythematosus, scleroderma, vasculitides, or Takayasu's arteritis. Treatment includes avoiding triggers like cold temperatures, stress, smoking, and caffeine, and occasionally using a medication like a calcium channel blocker to help with vasodilation of the arteries. In severe cases, surgery may be necessary to cut the sympathetic nerve fibers supplying the affected areas and improve blood flow.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  5. "Aspects héréditaires et génétiques de la maladie de Raynaud" Journal des Maladies Vasculaires (2006)
  6. "Raynaud’s Phenomenon" New England Journal of Medicine (2016)
  7. "Coexistence of erythromelalgia and Raynaud's phenomenon" Journal of the American Academy of Dermatology (2004)